Rana H. Besada
BioNTech (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Virus-based gene therapy research, Acute Lymphoblastic Leukemia research, CAR-T cell therapy research
Most-Cited Works
- → A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer(2020)717 cited
- → Endocardially Derived Macrophages Are Essential for Valvular Remodeling(2019)89 cited
- → Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1(2020)46 cited
- → In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1+ BCP-ALL(2018)15 cited
- → Abstract 942: The personalized vaccine, NEO-PV-01 with anti-PD1, induces neoantigen-specific de novo immune responses in patients with advanced metastatic melanoma: Association with clinical outcomes(2019)8 cited
- → Abstract 5006: Comprehensive gene expression analysis of the tumor microenvironment in patients with advanced cancer treated with a personalized neoantigen vaccine, NEO-PV-01, in combination with anti-PD1(2019)1 cited
- BiTEs and CAR-Ts : immunotherapy in childhood B-cell acute lymphoblastic leukemia(2018)